The PPARγ ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo.
about
Vascular endothelin receptor type B: structure, function and dysregulation in vascular diseasePPARγ attenuates hypoxia-induced hypertrophic transcriptional pathways in the heart.Time-dependent PPARγ Modulation of HIF-1α Signaling in Hypoxic Pulmonary Artery Smooth Muscle Cells.The microRNA-130/301 family controls vasoconstriction in pulmonary hypertensionChronic hypoxia promotes pulmonary artery endothelial cell proliferation through H2O2-induced 5-lipoxygenase.Impact of diabetes in patients with pulmonary hypertensionPPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21.Transforming growth factor beta 1 induced endothelin-1 release is peroxisome proliferator-activated receptor gamma dependent in A549 cellsRegulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis.Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.Peroxisome proliferator-activated receptor gamma (PPARγ) regulates thrombospondin-1 and Nox4 expression in hypoxia-induced human pulmonary artery smooth muscle cell proliferationRelaxation of human pulmonary arteries by PPARγ agonists.Human immunodeficiency virus-1 transgene expression increases pulmonary vascular resistance and exacerbates hypoxia-induced pulmonary hypertension development.Proline-rich tyrosine kinase 2 downregulates peroxisome proliferator-activated receptor gamma to promote hypoxia-induced pulmonary artery smooth muscle cell proliferation.Reactive oxygen species as therapeutic targets in pulmonary hypertension.Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.Skeletal Muscle Vascular Function: A Counterbalance of Insulin Action.Enhanced Clearance of Pseudomonas aeruginosa by Peroxisome Proliferator-Activated Receptor GammaHypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells.Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.Endothelin-1 decreases endothelial PPARγ signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension.Eggshell membrane ameliorates hepatic fibrogenesis in human C3A cells and rats through changes in PPARγ-Endothelin 1 signaling.Hypoxia mediates mutual repression between microRNA-27a and PPARγ in the pulmonary vasculature.Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation.Chronic hypoxia alters fetal cerebrovascular responses to endothelin-1.Peroxisome proliferator-activated receptor-γ enhances human pulmonary artery smooth muscle cell apoptosis through microRNA-21 and programmed cell death 4.Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH.
P2860
Q28263963-2831DDDC-DB90-48FC-A415-400A21B44CFEQ33738569-9ACEEDAA-51B8-46DA-AAE0-B5C89673CD3AQ33831356-5147A38E-AC81-488A-BFB3-E7528623154CQ35002833-0FC8847D-C3C0-4DDA-B946-5D6AF5C2C010Q35183085-5E26E6EE-AF2A-4194-948C-2C6893750CEFQ35517404-52DD0620-39A8-4FDB-A196-E091C5234B4AQ35711530-AD4D5A71-E788-4759-B644-2D14FE586F6AQ36049930-2A592678-A438-4E85-B848-DF343698E4B9Q36093802-CC58AC47-789C-4D46-B05D-C7E3DE402F0FQ36549041-CD015DEB-3BDF-4771-988C-340A5BBB2F66Q36563581-CAA82C9C-4B44-404B-9473-AFD974142F33Q36755896-91C443C2-2052-4398-A312-1F42FE5E5BACQ36810837-74CF9D2F-682A-48C8-A074-A8235F4131F6Q36908849-824AAFC4-AD3A-4F0D-A8F3-21FAA7F9284EQ38074770-862FA7CF-109F-43C1-B64D-DE0DCE7D150EQ38259551-5213F584-3303-4189-8634-A2548E36DBB4Q38436848-318E05A1-6B1A-434D-812D-013878061953Q38777230-7A6176CF-4A27-4AB2-86E6-3A5DE7CF227EQ39150404-D88E2FB1-3EF3-4E0F-A4BF-4A2732B0C81EQ40588101-13228D7D-5A73-4E5A-A768-EA36523A1EF6Q41943805-4C438240-BD4C-47E9-AA4C-CF3DB4A022A5Q42292936-64851CCD-263C-4FF0-A6E9-535A1D1973BFQ42593185-64BBBC31-54D0-47CC-A4F2-9B0FF3CB10E6Q42746715-7EE70759-A1C1-4D86-A4BF-F648C09E859BQ43182141-AEDD5345-8FF0-470C-B330-FC4BE6BCAE7BQ46056406-B4CD8A2E-8269-488B-BA41-E5B1C9383B3BQ47074392-D7D044C4-25D7-4D08-928D-D035F591E685Q53686493-A81B646B-D562-44EB-980F-FFA6F912340A
P2860
The PPARγ ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The PPARγ ligand rosiglitazone ...... ignaling in vitro and in vivo.
@en
The PPARγ ligand rosiglitazone ...... ignaling in vitro and in vivo.
@nl
type
label
The PPARγ ligand rosiglitazone ...... ignaling in vitro and in vivo.
@en
The PPARγ ligand rosiglitazone ...... ignaling in vitro and in vivo.
@nl
prefLabel
The PPARγ ligand rosiglitazone ...... ignaling in vitro and in vivo.
@en
The PPARγ ligand rosiglitazone ...... ignaling in vitro and in vivo.
@nl
P2093
P2860
P1476
The PPARγ ligand rosiglitazone ...... ignaling in vitro and in vivo.
@en
P2093
Bum-Yong Kang
C Michael Hart
Jennifer M Kleinhenz
Tamara C Murphy
P2860
P304
P356
10.1152/AJPLUNG.00195.2011
P577
2011-09-16T00:00:00Z